Ledger.Open graph →
SEC Form D · filed October 7, 2024

Morphoceuticals, Inc

Offering
$5.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Medford, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

James R. Jenson · Medford, MAExec · DirectorMichael R. Hufford · Medford, MADirectorAlexander R. Pickett · Medford, MADirectorJustin R. Briggs · Medford, MADirectorTamim H. Al-Thani · Medford, MADirectorRosemarie R. Hunziker · Medford, MADirectorJames Jenson · Medford, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗